GELITA AG
GELITA AG, established in 1875 and headquartered in Germany, is a preeminent global manufacturer of gelatin and collagen products, serving the food, pharmaceutical, health and nutrition, and cosmetics industries. The company’s diverse product line encompasses standard and specialty gelatins, collagen peptides, and collagen proteins. With over 22 production sites and sales offices in more than 20 countries, GELITA AG maintains a significant global footprint. In the collagen and gelatin sector, GELITA AG stands out for its strong commitment to research and development (R&D), often collaborating with universities and research institutions to drive innovation. A key focus is on its scientifically backed bioactive collagen peptides, which are specifically designed for improving joint health, bone density, and skin rejuvenation. The company also produces materials like fats, minerals, and proteins as by-products, which are utilized in animal feed and as energy sources, demonstrating a holistic approach to raw material use. This focus on scientific validation and global scale cements GELITA AG’s position as a market leader in delivering high-quality, functional collagen and gelatin ingredients.
Latest Market Research Report on Collagen and Gelatin Download PDF Brochure Now
Rousselot SAS (Darling Ingredients)
Rousselot SAS, founded in 1891 in France, is a world-leading manufacturer of gelatin, collagen peptides, and other protein-based ingredients, operating as a key business unit of the US-based Darling Ingredients Inc. The company holds a strong position in the market by supplying gelatin and hydrolyzed collagen across the food, nutrition, pharmaceutical, and technical sectors globally. Rousselot offers a specialized range of bioactive collagen peptides designed to target specific health benefits, including joint health, skin beauty, and sports nutrition, which are crucial for the high-growth nutraceutical industry. The company operates 11 production plants with quality control laboratories and 10 sales locations, distributing its products to over 75 countries. Rousselot is committed to high-quality, safe, and environmentally sound production, focusing on the sustainable use of agricultural, industrial, and food by-products. This commitment led to a recent reorganization into three strategic segments: Rousselot Health and Nutrition, Rousselot Biomedical, and Rousselot Functional Ingredients, enabling a highly focused approach to serve its diverse industrial clientele with tailored, innovative, and functional protein solutions.
PB Leiner (Tessenderlo Group)
PB Leiner, established around 1900, is a major global player in the gelatin and collagen industry, forming a key part of the Tessenderlo Group’s Bio-valorization segment. Operating production sites across Asia, Europe, North America, and South America, the company is a global distributor of a complete range of high-quality gelatins and collagen peptides, sourced from pigskin, cattle hide, and bovine bones. PB Leiner’s strategy is centered on developing convenient, modern gelatin-based solutions, which offer significant advantages to customers by saving time, increasing flexibility, and reducing cost-in-use. A notable expansion of its specialty range includes the introduction of cold-soluble gelatin products, catering to the evolving demands of the food and sports nutrition markets. The company’s products are utilized in consumer goods, construction, agriculture, food, and industrial applications. As a subsidiary of the Tessenderlo Group, which is a diverse industrial conglomerate, PB Leiner benefits from a strong operational backbone and a global presence with manufacturing plants and offices in 26 countries, ensuring reliable and high-standard product delivery to customers across more than 100 locations worldwide. This robust network and innovation focus solidify PB Leiner’s competitive position in the global market.
Nitta Gelatin Inc.
Nitta Gelatin, with over a century of expertise since its founding in Osaka, Japan, is a trusted global supplier of gelatin and collagen ingredients for the food, dietary supplement, and pharmaceutical markets. The company has grown into a global entity with 11 group companies operating across six countries. Nitta Gelatin is recognized as an industry leader, consistently supplying high-quality gelatin and collagen peptide products. Their commitment to innovation is evident in their specialty product lines, such as beMatrix® biomedical gelatin, which is controlled for exceptionally low endotoxin levels and high purity, making it ideal for advanced biomedical applications like cell sheet transportation and bone void fillers. Other notable innovations include XactSet® gelatin, a rapid-set solution for starchless gummy manufacturing that cuts setting time from hours to minutes, and CapsiGuard™ DRG Gelatin for soft capsules that ensures complete dissolution upon ingestion. Nitta Gelatin also actively develops fish-derived collagen peptides known for their superior bioavailability and customized solutions for skin and bone health. This continuous focus on technical expertise, application support, and global expansion reinforces Nitta Gelatin’s role as a leading innovator in the functional ingredients sector.
SAS Gelatines Weishardt (Weishardt International)
SAS Gelatines Weishardt, founded in 1989 and headquartered in France, is a significant global supplier of high-quality pig and fish skin gelatine, fish collagen peptides, and texturizing systems. The company caters to the food and beverage, nutrition, pharmaceutical, and beauty industries, specializing in premium products. Weishardt’s reputation is built on producing the highest standards of food quality, utilizing a specific process that results in enhanced solubility for its gelatin products. A key area of expertise is in marine-sourced collagen peptides, highlighted by their Naticol® range. The Naticol® fish collagen peptides are clinically proven to promote skin elasticity and hydration, offering high bioavailability, which positions the company at the forefront of the nutricosmetics and functional food segments. Beyond product quality, Weishardt is deeply committed to sustainable business practices. The company actively works to protect the environment, safeguarding its employees and focuses on minimizing the use of water and energy while decreasing waste production. This combination of specialized marine collagen expertise, high-quality manufacturing, and dedication to sustainability makes Weishardt a respected and influential player in the global collagen and gelatin market.
Darling Ingredients Inc.
Darling Ingredients Inc., headquartered in the U.S., is a major global player in the collagen and gelatin sector, primarily through its Rousselot subsidiary, which falls under its Food Ingredients segment. While the company operates across three broad segments—Feed Ingredients, Food Ingredients, and Fuel Ingredients—its influence in the gelatin market is vast, leveraging its status as a top manufacturer of sustainable natural ingredients. With a network of 270 plants across five continents, Darling Ingredients uniquely transforms approximately 10% of the global meat industry’s waste streams into valuable products, which include collagen, animal proteins, and renewable diesel. The vertically integrated operations of Darling and Rousselot guarantee consistent quality and reliable global delivery of collagen and hydrolyzed collagen. This scale and commitment to sustainability make them a prime partner for diversified multinational brands. Rousselot, as a business unit, focuses on producing gelatin and hydrolyzed collagen for the food, nutrition, pharmaceutical, and technical sectors, with specialized bioactive collagen peptides targeting joint health and skin beauty. Darling’s overall business model—harnessing global scale, commitment to sustainability, and raw material access—provides a significant, integrated advantage in the collagen and gelatin supply chain.
Evonik Industries AG
Evonik Industries AG, headquartered in Essen, Germany, is a specialty chemicals company making a unique and significant contribution to the collagen market through its focus on sustainable and high-purity alternatives to traditional animal-derived collagen. Evonik’s innovative approach centers on fermentation-based collagen production. This disruptive technology allows for the creation of non-animal-derived collagen that is highly suitable for clean-label, vegan-friendly applications, and the demanding medical and pharmaceutical sectors. This method addresses the increasing ethical, allergen, and sustainability concerns of consumers and specialized industries. The fermentation process ensures a high-purity product, making it a valuable ingredient for advanced wound care, tissue engineering, and other high-end biomedical applications. By utilizing its advanced technology platform, Evonik is positioned to offer a sustainable, scalable, and fully traceable source of collagen. This strategic focus on alternative production methods and high-purity materials distinguishes Evonik as a forward-thinking market leader, providing the industry with the next generation of collagen materials that meet stringent regulatory and consumer preference standards globally.
Amicogen Co., Ltd.
Amicogen Co., Ltd. (Amicogen Inc.), a leading biotechnology company based in Korea, plays a crucial role in the collagen and gelatin sector through its advanced enzymatic hydrolysis technologies. The company is renowned for developing, producing, and selling enzyme-based new functional materials and specialized biocatalysts. By leveraging its proprietary enzymatic methods, Amicogen is capable of yielding high-purity collagen peptides with superior bioactivity, which are highly valued in the global food and pharmaceutical industries. Its focus on collaboration with major global food and pharmaceutical brands ensures the scalability and customization necessary for specialized health and beauty applications. Amicogen’s product offerings include not only collagen peptides but also other enzyme-derived materials like Endo-chitosane and nuclease sm, which are used in various biotechnology processes, including reducing viscosity and protein purification. By integrating sustainability into its sourcing and R&D strategies and emphasizing clean-label, science-backed ingredients, Amicogen maintains a strong competitive edge. This commitment to biotechnological innovation in the production of functional ingredients positions Amicogen as a critical supplier for companies seeking next-generation, high-performance collagen and gelatin solutions.
BioCell Technology, LLC.
BioCell Technology, LLC. is a prominent ingredient supplier in the collagen market, specifically recognized for its flagship and clinically researched ingredient, BioCell Collagen®. The company’s focus is on providing patented ingredient delivery systems that target specific consumer health needs, primarily joint health, skin rejuvenation, and sports recovery. BioCell Collagen® is a naturally occurring matrix of hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid, a unique composition that is highly sought after by major global supplement brands. The firm’s commitment to scientific validation is a key differentiator, with its ingredient supported by robust, peer-reviewed clinical trials. This emphasis on science-backed efficacy has made BioCell Technology a trusted partner for premium supplement manufacturers targeting wellness-oriented consumers who prioritize proven benefits. By maintaining a sharp focus on its patented ingredient and providing comprehensive scientific data, BioCell Technology has carved out a specialty niche in the competitive collagen landscape. This strategy allows the company to continuously drive market demand for its premium, specialized ingredient, solidifying its reputation as a leader in innovative, research-driven functional food and nutraceutical solutions.
CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. is a pioneering leader in the collagen sector, distinguished by its development of recombinant human collagen (rhCollagen) produced from genetically engineered tobacco plants. This disruptive technology fundamentally addresses ethical, allergen, and sustainability concerns associated with animal-derived collagen sources. CollPlant’s rhCollagen is a game-changer, particularly for advanced biomedical applications. It is utilized in advanced wound care, regenerative medicine, and is a foundational material for 3D bioprinting, including the bioprinting of organs and tissues. The company’s technology platform enables the production of high-purity, safe, and reproducible collagen identical to the natural Type I human collagen. CollPlant’s focus is firmly on medical-grade solutions, partnering with medical device manufacturers and research institutions to deliver clinically relevant, innovative collagen-based products. By offering a product that eliminates the risk of transmitting animal-borne pathogens and can be customized for specific medical applications, CollPlant is not just a collagen supplier but a forward-thinking market leader. Its biotechnology-based approach is accelerating the shift toward safer and more sustainable materials in the fields of tissue engineering and bioprinting.
Collagen Solutions Ltd.
Collagen Solutions Ltd. specializes in providing high-quality, medical-grade collagen materials and components, specifically tailored for the biomedical and medical device sectors. The company is renowned for its expertise in custom project development, working closely with medical device manufacturers, particularly in the fields of tissue repair, regenerative medicine, and advanced wound care. Collagen Solutions’ products include various forms of collagen, such as scaffolds and other functionalized materials, which are essential for creating innovative and reliable medical devices. Their stringent quality control and ability to customize the collagen material—including type, purity, and format—to precise clinical and regulatory standards sets them apart in the market. By maintaining a sharp focus on the high-value, highly regulated biomedical applications, the company has established itself as a trusted partner in delivering clinically relevant collagen-based solutions worldwide. Their strategic emphasis on R&D and collaboration in the medical field ensures their collagen products are at the cutting edge of regenerative technology, supporting advancements in surgical, orthopedic, and dental applications. This specialization allows Collagen Solutions to play a pivotal, high-impact role in the global market.
Vital Proteins LLC.
Vital Proteins LLC, based in Chicago, Illinois, is a dominant brand in the consumer-facing collagen supplement market, known for its high-quality, wellness-focused product range. The company has successfully cultivated a leading position by targeting the growing consumer demand for natural, functional ingredients that support beauty and wellness from within. Vital Proteins’ extensive product portfolio includes a variety of collagen peptides, creamers, gummies, and specialized blends, all primarily aimed at promoting joint health, skin hydration, and overall well-being. A core part of their brand identity is their commitment to clean sourcing, often using grass-fed, pasture-raised bovine collagen, which resonates strongly with health-conscious consumers. The company’s strategic focus is on delivering convenient, easily incorporated products that fit seamlessly into consumers’ daily routines, supported by an effective direct-to-consumer and retail strategy. By consistently innovating with new product formats and flavors and maintaining a strong market presence as a trusted consumer brand, Vital Proteins has not only capitalized on the collagen trend but has also been instrumental in shaping it. This brand-first approach makes them a key driver of market growth in the B2C segment of the global collagen industry.
Lapi Gelatine S.p.A.
Lapi Gelatine S.p.A., an Italian company with roots tracing back to 1966, is an international market leader specializing in the production of top-quality gelatin and collagen peptides. The company is particularly renowned for its sustainably sourced bovine and fish collagen products, which are manufactured in Italy. Lapi Gelatine’s expertise lies in its focus on clean-label and high-purity collagen peptides, making them a preferred supplier for the food, nutraceutical, pharmaceutical, and cosmetic sectors. With decades of experience, the company serves clients across 52 countries, ranging from large multinational businesses to small and medium production companies. Their commitment to superior quality extends across their product line, which includes gelatin, instant cold-soluble gelatin, and hydrolyzed collagen. Lapi Gelatine’s continuous innovation is centered on meeting both stringent regulatory requirements and the rising market demand for natural, high-performance ingredients. This strategic dedication to quality, global distribution, and a focus on both traditional gelatin and advanced collagen peptides ensures Lapi Gelatine remains a major, reliable player in the global collagen and gelatin supply chain, providing essential, high-purity ingredients to a wide array of industrial partners.
Latest Market Research Report on Collagen and Gelatin Download PDF Brochure Now